COVID-19 Impact on Global Infectious Disease Drugs Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Infectious Disease Drugs Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Infectious Disease Drugs Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Antibacterials
  • 1.4.3 Antiviral drugs
  • 1.4.4 Antiparasitic drugs
  • 1.4.5 Antifungal
  • 1.4.6 Others
• 1.5 Market by Application
  • 1.5.1 Global Infectious Disease Drugs Market Share by Application: 2020 VS 2026
  • 1.5.2 HIV
  • 1.5.3 Malaria
  • 1.5.4 Hepatitis
  • 1.5.5 Influenza
  • 1.5.6 HPV
  • 1.5.7 Tuberculosis
  • 1.5.8 Others
• 1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Drugs Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Infectious Disease Drugs Industry
    • 1.6.1.1 Infectious Disease Drugs Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Infectious Disease Drugs Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Infectious Disease Drugs Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Infectious Disease Drugs Market Perspective (2015-2026)
• 2.2 Infectious Disease Drugs Growth Trends by Regions
  • 2.2.1 Infectious Disease Drugs Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Infectious Disease Drugs Historic Market Share by Regions (2015-2020)
  • 2.2.3 Infectious Disease Drugs Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Infectious Disease Drugs Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Infectious Disease Drugs Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Infectious Disease Drugs Players by Market Size
  • 3.1.1 Global Top Infectious Disease Drugs Players by Revenue (2015-2020)
  • 3.1.2 Global Infectious Disease Drugs Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Infectious Disease Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Infectious Disease Drugs Market Concentration Ratio
  • 3.2.1 Global Infectious Disease Drugs Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Infectious Disease Drugs Revenue in 2019
• 3.3 Infectious Disease Drugs Key Players Head office and Area Served
• 3.4 Key Players Infectious Disease Drugs Product Solution and Service
• 3.5 Date of Enter into Infectious Disease Drugs Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Infectious Disease Drugs Historic Market Size by Type (2015-2020)
• 4.2 Global Infectious Disease Drugs Forecasted Market Size by Type (2021-2026)

5 Infectious Disease Drugs Breakdown Data by Application (2015-2026)

• 5.1 Global Infectious Disease Drugs Market Size by Application (2015-2020)
• 5.2 Global Infectious Disease Drugs Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Infectious Disease Drugs Market Size (2015-2020)
• 6.2 Infectious Disease Drugs Key Players in North America (2019-2020)
• 6.3 North America Infectious Disease Drugs Market Size by Type (2015-2020)
• 6.4 North America Infectious Disease Drugs Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Infectious Disease Drugs Market Size (2015-2020)
• 7.2 Infectious Disease Drugs Key Players in Europe (2019-2020)
• 7.3 Europe Infectious Disease Drugs Market Size by Type (2015-2020)
• 7.4 Europe Infectious Disease Drugs Market Size by Application (2015-2020)

8 China

• 8.1 China Infectious Disease Drugs Market Size (2015-2020)
• 8.2 Infectious Disease Drugs Key Players in China (2019-2020)
• 8.3 China Infectious Disease Drugs Market Size by Type (2015-2020)
• 8.4 China Infectious Disease Drugs Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Infectious Disease Drugs Market Size (2015-2020)
• 9.2 Infectious Disease Drugs Key Players in Japan (2019-2020)
• 9.3 Japan Infectious Disease Drugs Market Size by Type (2015-2020)
• 9.4 Japan Infectious Disease Drugs Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Infectious Disease Drugs Market Size (2015-2020)
• 10.2 Infectious Disease Drugs Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Infectious Disease Drugs Market Size by Type (2015-2020)
• 10.4 Southeast Asia Infectious Disease Drugs Market Size by Application (2015-2020)

11 India

• 11.1 India Infectious Disease Drugs Market Size (2015-2020)
• 11.2 Infectious Disease Drugs Key Players in India (2019-2020)
• 11.3 India Infectious Disease Drugs Market Size by Type (2015-2020)
• 11.4 India Infectious Disease Drugs Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Infectious Disease Drugs Market Size (2015-2020)
• 12.2 Infectious Disease Drugs Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Infectious Disease Drugs Market Size by Type (2015-2020)
• 12.4 Central & South America Infectious Disease Drugs Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 GlaxoSmithKline
  • 13.1.1 GlaxoSmithKline Company Details
  • 13.1.2 GlaxoSmithKline Business Overview and Its Total Revenue
  • 13.1.3 GlaxoSmithKline Infectious Disease Drugs Introduction
  • 13.1.4 GlaxoSmithKline Revenue in Infectious Disease Drugs Business (2015-2020))
  • 13.1.5 GlaxoSmithKline Recent Development
• 13.2 Gilead Sciences
  • 13.2.1 Gilead Sciences Company Details
  • 13.2.2 Gilead Sciences Business Overview and Its Total Revenue
  • 13.2.3 Gilead Sciences Infectious Disease Drugs Introduction
  • 13.2.4 Gilead Sciences Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.2.5 Gilead Sciences Recent Development
• 13.3 Merck & Co.
  • 13.3.1 Merck & Co. Company Details
  • 13.3.2 Merck & Co. Business Overview and Its Total Revenue
  • 13.3.3 Merck & Co. Infectious Disease Drugs Introduction
  • 13.3.4 Merck & Co. Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.3.5 Merck & Co. Recent Development
• 13.4 Pfizer
  • 13.4.1 Pfizer Company Details
  • 13.4.2 Pfizer Business Overview and Its Total Revenue
  • 13.4.3 Pfizer Infectious Disease Drugs Introduction
  • 13.4.4 Pfizer Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.4.5 Pfizer Recent Development
• 13.5 Sanofi
  • 13.5.1 Sanofi Company Details
  • 13.5.2 Sanofi Business Overview and Its Total Revenue
  • 13.5.3 Sanofi Infectious Disease Drugs Introduction
  • 13.5.4 Sanofi Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.5.5 Sanofi Recent Development
• 13.6 AbbVie
  • 13.6.1 AbbVie Company Details
  • 13.6.2 AbbVie Business Overview and Its Total Revenue
  • 13.6.3 AbbVie Infectious Disease Drugs Introduction
  • 13.6.4 AbbVie Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.6.5 AbbVie Recent Development
• 13.7 Shire
  • 13.7.1 Shire Company Details
  • 13.7.2 Shire Business Overview and Its Total Revenue
  • 13.7.3 Shire Infectious Disease Drugs Introduction
  • 13.7.4 Shire Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.7.5 Shire Recent Development
• 13.8 Grifols
  • 13.8.1 Grifols Company Details
  • 13.8.2 Grifols Business Overview and Its Total Revenue
  • 13.8.3 Grifols Infectious Disease Drugs Introduction
  • 13.8.4 Grifols Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.8.5 Grifols Recent Development
• 13.9 Johnson & Johnson
  • 13.9.1 Johnson & Johnson Company Details
  • 13.9.2 Johnson & Johnson Business Overview and Its Total Revenue
  • 13.9.3 Johnson & Johnson Infectious Disease Drugs Introduction
  • 13.9.4 Johnson & Johnson Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.9.5 Johnson & Johnson Recent Development
• 13.10 Protein Sciences
  • 13.10.1 Protein Sciences Company Details
  • 13.10.2 Protein Sciences Business Overview and Its Total Revenue
  • 13.10.3 Protein Sciences Infectious Disease Drugs Introduction
  • 13.10.4 Protein Sciences Revenue in Infectious Disease Drugs Business (2015-2020)
  • 13.10.5 Protein Sciences Recent Development
• 13.11 AstraZeneca
  • 10.11.1 AstraZeneca Company Details
  • 10.11.2 AstraZeneca Business Overview and Its Total Revenue
  • 10.11.3 AstraZeneca Infectious Disease Drugs Introduction
  • 10.11.4 AstraZeneca Revenue in Infectious Disease Drugs Business (2015-2020)
  • 10.11.5 AstraZeneca Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer